Chandra Rashmi, Parra Roberto, Iqbal Hafiz M N
School of Engineering and Science, Tecnologico de Monterrey, Campus Monterrey, Ave. Eugenio Garza Sada 2501, Monterrey, N. L., CP 64849, Mexico.
Protein Pept Lett. 2017;24(2):118-125. doi: 10.2174/0929866523666160802160222.
Marine species are comprising about a half of the whole global biodiversity; the sea offers an enormous resource for novel bioactive compounds. Several of the marine origin species show multifunctional bioactivities and characteristics that are useful for a discovery and/or reinvention of biologically active compounds. For millennia, marine species that includes cyanobacteria (blue-green algae) and red algae have been targeted to explore their enormous potential candidature status along with a wider spectrum of novel applications in bio- and non-bio sectors of the modern world. Among them, cyanobacteria are photosynthetic prokaryotes, phylogenetically a primitive group of Gramnegative prokaryotes, ranging from Arctic to Antarctic regions, capable of carrying out photosynthesis and nitrogen fixation. In the recent decade, a great deal of research attention has been paid on the pronouncement of bio-functional proteins along with novel peptides, vitamins, fine chemicals, renewable fuel and bioactive compounds, e.g., phycobiliproteins from marine species, cyanobacteria and red algae. Interestingly, they are extensively commercialized for natural colorants in food and cosmetics, antimicrobial, antioxidant, anti-inflammatory, neuroprotective, hepatoprotective agents and fluorescent neo-glycoproteins as probes for single particle fluorescence imaging fluorescent applications in clinical and immunological analysis. However, a comprehensive knowledge and technological base for augmenting their commercial utilities are lacking. Therefore, this paper will provide an overview of the phycobiliproteins-based research literature from marine cyanobacteria and red algae. This review is also focused towards analyzing global and commercial activities with application oriented-based research. Towards the end, the information is also given on the potential biotechnological and biomedical applications of phycobiliproteins.
海洋物种约占全球生物多样性的一半;海洋为新型生物活性化合物提供了巨大资源。一些海洋源物种具有多功能生物活性和特性,有助于发现和/或重新发明生物活性化合物。数千年来,包括蓝细菌(蓝藻)和红藻在内的海洋物种一直是探索其巨大潜在候选地位以及在现代世界生物和非生物领域更广泛新型应用的目标。其中,蓝细菌是光合原核生物,在系统发育上是革兰氏阴性原核生物的一个原始类群,分布于北极到南极地区,能够进行光合作用和固氮。在最近十年中,人们对生物功能蛋白以及新型肽、维生素、精细化学品、可再生燃料和生物活性化合物的发现给予了大量研究关注,例如来自海洋物种、蓝细菌和红藻的藻胆蛋白。有趣的是,它们在食品和化妆品中作为天然色素、抗菌剂、抗氧化剂、抗炎剂、神经保护剂、肝保护剂以及作为单粒子荧光成像荧光探针在临床和免疫分析中的荧光新糖蛋白等方面得到了广泛商业化应用。然而,目前缺乏增强其商业用途的全面知识和技术基础。因此,本文将概述来自海洋蓝细菌和红藻的基于藻胆蛋白的研究文献。本综述还侧重于分析基于应用的研究的全球和商业活动。最后,还介绍了藻胆蛋白潜在的生物技术和生物医学应用信息。